{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T21:59:20Z","timestamp":1789250360498,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,16]],"date-time":"2025-02-16T00:00:00Z","timestamp":1739664000000},"content-version":"am","delay-in-days":352,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.xphs.2023.11.035","type":"journal-article","created":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T17:50:43Z","timestamp":1702144243000},"page":"791-797","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["An Automated Electroanalytical Method for the Drug Release Profiling of Liposomal Doxorubicin HCl Formulations"],"prefix":"10.1016","volume":"113","author":[{"given":"Fatma","family":"Yurtsever","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4071-6690","authenticated-orcid":false,"given":"Thilak","family":"Mudalige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2023.11.035_bib0001","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/456409","article-title":"Liposomal Doxorubicin in the treatment of breast cancer patients: a review","volume":"2013","author":"Lao","year":"2013","journal-title":"J Drug Deliv"},{"issue":"2","key":"10.1016\/j.xphs.2023.11.035_bib0002","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3109\/03639049109043818","article-title":"Drug release rate method for a liposome preparation","volume":"17","author":"Vemuri","year":"1991","journal-title":"Drug Dev Ind Pharm"},{"issue":"14","key":"10.1016\/j.xphs.2023.11.035_bib0003","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJM197609302951406","article-title":"The carrier potential of liposomes in biology and medicine","volume":"295","author":"Gregoriadis","year":"1976","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.xphs.2023.11.035_bib0004","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1139\/y79-081","article-title":"Factors affecting the encapsulation of drugs within liposomes","volume":"57","author":"Stamp","year":"1979","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.xphs.2023.11.035_bib0005","series-title":"Drug Delivery Systems: Characteristics and Biomedical Applications","author":"Juliano","year":"1980"},{"key":"10.1016\/j.xphs.2023.11.035_bib0006","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jchromb.2018.05.028","article-title":"Novel analytical methods to assess the chemical and physical properties of liposomes","volume":"1091","author":"Kothalawala","year":"2018","journal-title":"J Chromatogr B"},{"key":"10.1016\/j.xphs.2023.11.035_bib0007","series-title":"Handbook of Materials for Nanomedicine: Lipid-Based and Inorganic Nanomaterials","first-page":"157","article-title":"Liposomal drug delivery system and its clinically available products","author":"Bulbake","year":"2020"},{"issue":"1-3","key":"10.1016\/j.xphs.2023.11.035_bib0008","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0168-3659(97)00261-7","article-title":"Development of liposomal anthracyclines: from basics to clinical applications","volume":"53","author":"Gabizon","year":"1998","journal-title":"J Controlled Release"},{"issue":"14","key":"10.1016\/j.xphs.2023.11.035_bib0009","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1200\/JCO.2001.19.14.3312","article-title":"Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan","volume":"19","author":"Gordon","year":"2001","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.xphs.2023.11.035_bib0010","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0378-5173(83)90130-8","article-title":"Preparation and characterization of doxorubicin-containing liposomes: I. Influence of liposome charge and pH of hydration medium on loading capacity and particle size","volume":"16","author":"Crommelin","year":"1983","journal-title":"Int J Pharm"},{"issue":"7","key":"10.1016\/j.xphs.2023.11.035_bib0011","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/j.nano.2015.06.007","article-title":"In vitro experiments showing enhanced release of doxorubicin from Doxil(R) in the presence of ammonia may explain drug release at tumor site","volume":"11","author":"Silverman","year":"2015","journal-title":"Nanomedicine"},{"issue":"10","key":"10.1016\/j.xphs.2023.11.035_bib0012","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11101512","article-title":"Tumor drug distribution after local drug delivery by hyperthermia, in vivo","volume":"11","author":"Besse","year":"2019","journal-title":"Cancers"},{"issue":"1-2","key":"10.1016\/j.xphs.2023.11.035_bib0013","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0168-3659(99)00248-5","article-title":"Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review","volume":"65","author":"Maeda","year":"2000","journal-title":"J Controlled Release"},{"issue":"3","key":"10.1016\/j.xphs.2023.11.035_bib0014","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1124\/pr.115.012070","article-title":"Lipid-based drug delivery systems in cancer therapy: what is available and what is yet to come","volume":"68","author":"Yingchoncharoen","year":"2016","journal-title":"Pharmacol Rev"},{"issue":"2","key":"10.1016\/j.xphs.2023.11.035_bib0015","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil\u00ae \u2014 the first FDA-approved nano-drug: lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J Controlled Release"},{"issue":"5","key":"10.1016\/j.xphs.2023.11.035_bib0016","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0936-6555(05)80269-9","article-title":"Liposomal doxorubicin (Doxil): an effective new treatment for Kaposi's sarcoma in AIDS","volume":"6","author":"James","year":"1994","journal-title":"Clin Oncol"},{"key":"10.1016\/j.xphs.2023.11.035_bib0017","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ejpb.2016.04.011","article-title":"Insights into composition\/structure\/function relationships of Doxil(R) gained from \"high-sensitivity\" differential scanning calorimetry","volume":"104","author":"Wei","year":"2016","journal-title":"Eur J Pharm Biopharm"},{"issue":"2","key":"10.1016\/j.xphs.2023.11.035_bib0018","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0014-5793(92)80947-F","article-title":"Gelation of liposome interior A novel method for drug encapsulation","volume":"312","author":"Lasic","year":"1992","journal-title":"FEBS Lett"},{"key":"10.1016\/j.xphs.2023.11.035_bib0019","series-title":"Cancer Nanotechnology: Methods and Protocols","first-page":"211","article-title":"Preparation and characterization of doxorubicin liposomes","author":"Niu","year":"2010"},{"issue":"5","key":"10.1016\/j.xphs.2023.11.035_bib0020","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2165\/00003088-200342050-00002","article-title":"Pharmacokinetics of pegylated liposomal doxorubicin","volume":"42","author":"Gabizon","year":"2003","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"10.1016\/j.xphs.2023.11.035_bib0021","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/annonc\/mdh097","article-title":"Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX\u2122\/Doxil\u00ae) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancer","volume":"15","author":"O'Brien","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.xphs.2023.11.035_bib0022","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jconrel.2017.11.007","article-title":"Leakage kinetics of the liposomal chemotherapeutic agent Doxil: the role of dissolution, protonation, and passive transport, and implications for mechanism of action","volume":"269","author":"Russell","year":"2018","journal-title":"J Control Release"},{"issue":"6","key":"10.1016\/j.xphs.2023.11.035_bib0023","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1208\/s12248-017-0142-0","article-title":"Role of in vitro release methods in liposomal formulation development: challenges and regulatory perspective","volume":"19","author":"Solomon","year":"2017","journal-title":"AAPS J"},{"issue":"1","key":"10.1016\/j.xphs.2023.11.035_bib0024","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1208\/s12248-016-9958-2","article-title":"Development of a flow-through USP-4 apparatus drug release assay to evaluate doxorubicin liposomes","volume":"19","author":"Yuan","year":"2017","journal-title":"AAPS J"},{"issue":"16","key":"10.1016\/j.xphs.2023.11.035_bib0025","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1080\/00032719.2011.553010","article-title":"Electroanalytical methods for the determination of pharmaceuticals: a review of recent trends and developments","volume":"44","author":"Uslu","year":"2011","journal-title":"Anal Lett"},{"issue":"1","key":"10.1016\/j.xphs.2023.11.035_bib0026","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF02980041","article-title":"Electrochemical behavior and square wave voltammetric determination of doxorubicin hydrochloride","volume":"27","author":"Hahn","year":"2004","journal-title":"Arch Pharmacal Res"},{"issue":"1","key":"10.1016\/j.xphs.2023.11.035_bib0027","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jconrel.2009.08.002","article-title":"Real-time electrochemical monitoring of drug release from therapeutic nanoparticles","volume":"140","author":"Mora","year":"2009","journal-title":"J Controlled Release"},{"issue":"4","key":"10.1016\/j.xphs.2023.11.035_bib0028","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s40828-018-0073-0","article-title":"Square-wave voltammetry","volume":"4","author":"Mirceski","year":"2018","journal-title":"ChemTexts"},{"issue":"1","key":"10.1016\/j.xphs.2023.11.035_bib0029","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1021\/ac00279a004","article-title":"Square wave voltammetry","volume":"57","author":"Osteryoung","year":"1985","journal-title":"Anal Chem"},{"key":"10.1016\/j.xphs.2023.11.035_bib0030","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/816202","article-title":"Electrochemical reduction of quinones in different media: a review","volume":"2011","author":"Guin","year":"2011","journal-title":"Int J Electrochem"},{"issue":"38","key":"10.1016\/j.xphs.2023.11.035_bib0031","doi-asserted-by":"crossref","first-page":"34127","DOI":"10.1021\/acsomega.2c03427","article-title":"Activated glassy carbon electrode as an electrochemical sensing platform for the determination of 4-nitrophenol and dopamine in real samples","volume":"7","author":"Abdel-Aziz","year":"2022","journal-title":"ACS Omega"},{"issue":"46","key":"10.1016\/j.xphs.2023.11.035_bib0032","doi-asserted-by":"crossref","first-page":"9537","DOI":"10.1039\/C9SM01820D","article-title":"Rapid leakage from PEGylated liposomes triggered by bubbles","volume":"15","author":"Fujie","year":"2019","journal-title":"Soft matter"},{"issue":"1","key":"10.1016\/j.xphs.2023.11.035_bib0033","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/0005-2736(78)90374-7","article-title":"Spreading of liposomes at the air\/water interface","volume":"507","author":"Pattus","year":"1978","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.xphs.2023.11.035_bib0034","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ijpharm.2019.03.003","article-title":"Direct and simultaneous determination of intra-liposomal and external sulfate in liposomal doxorubicin formulations by capillary electrophoresis\/inductively coupled plasma-tandem mass spectrometry (CE\/ICP-MS\/MS)","volume":"561","author":"Ansar","year":"2019","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2023.11.035_bib0035","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jconrel.2015.08.024","article-title":"Mechanistic model and analysis of doxorubicin release from liposomal formulations","volume":"217","author":"Fugit","year":"2015","journal-title":"J Controlled Release"},{"issue":"4","key":"10.1016\/j.xphs.2023.11.035_bib0036","first-page":"251","article-title":"Ammonium ion level in serum affects doxorubicin release from liposomes","volume":"65","author":"Shibata","year":"2010","journal-title":"Pharmazie"},{"issue":"6","key":"10.1016\/j.xphs.2023.11.035_bib0037","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0021-9614(75)90183-4","article-title":"Thermodynamic quantities for the dissociation of the ammonium ion and for the ionization of aqueous ammonia over a wide temperature range","volume":"7","author":"Olofsson","year":"1975","journal-title":"The J Chem Thermodyn"},{"issue":"3","key":"10.1016\/j.xphs.2023.11.035_bib0038","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1021\/acsomega.7b01235","article-title":"Cardinal role of intraliposome doxorubicin-sulfate nanorod crystal in doxil properties and performance","volume":"3","author":"Wei","year":"2018","journal-title":"ACS Omega"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354923005099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354923005099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:43:41Z","timestamp":1758361421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354923005099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0022354923005099"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2023.11.035","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An Automated Electroanalytical Method for the Drug Release Profiling of Liposomal Doxorubicin HCl Formulations","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2023.11.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of American Pharmacists Association.","name":"copyright","label":"Copyright"}]}}